Relx Plc (NYSE:RELX) Announces Semi-annual Dividend of $0.56

Relx Plc (NYSE:RELX) announced a semi-annual dividend on Tuesday, February 18th,Wall Street Journal reports. Stockholders of record on Friday, May 9th will be paid a dividend of 0.5586 per share by the technology company on Wednesday, June 25th. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. This is a boost from Relx’s previous semi-annual dividend of $0.23.

Relx has raised its dividend by an average of 4.5% annually over the last three years. Relx has a dividend payout ratio of 60.2% meaning its dividend is sufficiently covered by earnings. Analysts expect Relx to earn $1.61 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 69.6%.

Relx Stock Down 0.4 %

Shares of Relx stock traded down $0.20 during trading on Tuesday, hitting $50.87. 432,577 shares of the company’s stock traded hands, compared to its average volume of 570,691. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.48 and a quick ratio of 0.42. The firm’s fifty day moving average price is $47.89 and its 200 day moving average price is $47.19. Relx has a twelve month low of $40.25 and a twelve month high of $51.99.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Redburn Atlantic assumed coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock. StockNews.com upgraded shares of Relx from a “hold” rating to a “buy” rating in a research report on Friday.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.